Biotech Values

[bladerunner1717]

More interesting than the diatribe about NVS is the validation of the MNTA reverse engineering technology. This seems to me to make MNTA the most sought after acquisition and/or teaming partner in biogenerics.

Flatlander,

I totally agree. I think that's what is missing in the Market reaction so far. As Dew says, the game here is just beginning.


Bladerunner